We are monitoring the impact of COVID-19 on Europe Plasma Protein Therapeutics Market Get in touch with us for detailed analysis Know More
Share on

Europe Plasma Protein Therapeutics Market Research Report – Segmented By Product Type, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 207
Pages: 132

Europe Plasma Protein Therapeutics Market Size (2022 to 2027)

The plasma protein therapeutics market size in Europe was estimated at USD 8762.44 Million in 2022. It is expected to reach USD 12868.94 Million by 2027, growing at a staggering CAGR of 7.99% between 2022 to 2027.

In the recent past, plasma protein became prominent in medical science. There are also many technological advancements in this sector. The primary process of the plasma protein is, fractionating the protein from plasma. This process is also the most economical and less costly process, which is one of the significant factors promoting the growth rate of the European plasma protein therapeutics market.

This market is also introducing new therapies such as new plasma-derived therapies. These therapies are gaining the demand for the European plasma protein therapeutics market. In addition, the prevalence of various diseases has noticed growing in the recent past. Therefore, the increasing prevalence of diseases such as Rabies, Tetanus, Hepatitis A&B, and varicella is expected to favor the market's growth rate.

Many new opportunities are being introduced in this market to accelerate the market growth. Increasing treatment of the diseases and recent technological advancements in this market from the research department is improving the efficiency of the plasma proteins. These technological advancements are boosting the market. By knowing about its efficiency, plasma proteins are starting to be used around the world. Therefore, people are interested in detecting the disease in the starting period. 

However, strict government policies, high cost of manufacturing, and complex treatment and manufacturing are a few of the factors expected to hamper the market's growth rate.

This research report on the European plasma protein therapeutics market has been segmented and sub-segmented into the following categories:

By Type: 

  • Immunoglobulins
  • Albumin
  • Coagulation Factor
  • Alpha-1 Proteinase Inhibitor
  • Others

By Application: 

  • Hemophilia
  • Primary Immunodeficiency Disorder
  • Idiopathic Thrombocytopenic Purpura
  • Secondary Immunodeficiency
  • Others

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Germany is predicted to account for the largest share of the European plasma protein therapeutics market during the forecast period. Many disorders such as bleeding disorders, autoimmune disorders, neurological and immune deficiency disorders are increasing. The rise in the population is also affecting the market's growth as neurological disorders are common in the elderly population.

Followed by Germany, the United Kingdom is predicted to occupy the second-largest share in the European market during the forecast period. Many key players in the biotechnology and pharmaceutical sectors are increasing their investments in the research and development department, increasing the market's growth. The research and development department is expanding the applications of plasma proteins is boosting the market. Around the world, the usage of therapeutic protein drugs is increasing in the treatment of clinical symptoms. It is introducing new opportunities in this market and is expected to drive this market.


Major market participants in the European Plasma Protein Therapeutics Market are Grifols, CSL Behring, Baxter, Krdrion, China Biologics, Octapharma, Chendu Inst Shire Plc.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 By Type                                                                        

                                5.1.1 Immunoglobulins                                                 

                                5.1.2 Albumin                                                   

                                5.1.3 Coagulation Factors                                                             

                                5.1.4 Alpha-1 proteinase inhibitor                                                            

                                5.1.5 Others                                                      

                5.2 By Application                                                                           

                                5.2.1 Hemophilia                                                             

                                5.2.2 Primary Immunodeficiency Disorder                                                           

                                5.2.3 Idiopathic Thrombocytopenic Purpura                                                        

                                5.2.4 Secondary Immunodeficiency                                                        

                                5.2.5 Others                                                      

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                6.2 U.K                                                                 

                6.3 Spain                                                                             

                6.4 Germany                                                                     

                6.5 Italy                                                                               

                6.6 France                                                                          

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 CSL Behring                                                

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Baxter                                                           

                8.3 Biotest                                                          

                8.4 China Biologics                                                          

                8.5 Grifols                                                           

                8.6 Kedrion                                                        

                8.7 Octapharma                                                               

                8.8 Shire Plc.                                                      

                8.9 Chengdu Inst.                                                            

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 


                a) List of Tables                                                                

                b) List of Figures                                                                              

  1. Europe Plasma Protein Therapeutics Market, By Type, From 2022 - 2027 (USD Million)
  2. Europe Plasma Protein Therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  3. Europe Immunoglobulins Market, By Region, From 2022 - 2027 (USD Million)
  4. Europe Albumin Market, By Region, From 2022 - 2027 (USD Million)
  5. Europe Coagulation Factors Market, By Region, From 2022 - 2027 (USD Million)
  6. Europe Alpha-1 proteinase inhibitor Market, By Region, From 2022 - 2027 (USD Million)
  7. Europe Others Market, By Region, From 2022 - 2027 (USD Million)
  8. Europe Hemophilia Market, By Region, From 2022 - 2027 (USD Million)
  9. Europe Primary Immunodeficiency Disorder Market, By Region, From 2022 - 2027 (USD Million)
  10. Europe Idiopathic Thrombocytopenic Purpura Market, By Region, From 2022 - 2027 (USD Million)
  11. Europe Secondary Immunodeficiency Market, By Region, From 2022 - 2027 (USD Million)
  12. Europe Others Market, By Region, From 2022 - 2027 (USD Million)
  13. U.K Plasma Protein Therapeutics Market, By Type, From 2022 - 2027 (USD Million)
  14. Spain Plasma Protein Therapeutics Market, By Type, From 2022 - 2027 (USD Million)
  15. Germany Plasma Protein Therapeutics Market, By Type, From 2022 - 2027 (USD Million)
  16. Italy Plasma Protein Therapeutics Market, By Type, From 2022 - 2027 (USD Million)
  17. France Plasma Protein Therapeutics Market, By Type, From 2022 - 2027 (USD Million)
  18. U.K Plasma Protein Therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  19. Spain Plasma Protein Therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  20. Germany Plasma Protein Therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  21. Italy Plasma Protein Therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  22. France Plasma Protein Therapeutics Market, By Application From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports




pdf excel


pdf excel powerbi




What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.

Talk to our analyst and get customised report done according to your research needs


Check if you can avail any discount. Submit your details and our team will get back to you.


Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?

Find it too expensive?

Click for Request Sample